Copyright
        ©The Author(s) 2018.
    
    
        World J Clin Cases. Nov 6, 2018; 6(13): 600-610
Published online Nov 6, 2018. doi: 10.12998/wjcc.v6.i13.600
Published online Nov 6, 2018. doi: 10.12998/wjcc.v6.i13.600
            Table 1 Demographic and clinical characteristics of the participants in the study groups
        
    | HC | CHB | LC | HCC | P-value | |
| Characteristic | (n = 78) | (n = 78) | (n = 85) | (n = 77) | |
| Gender (M/F) | 48/30 | 53/25 | 54/31 | 62/15 | 0.05 | 
| Age (yr) | 44 (25-67) | 46 (30-61) | 49 (27-65) | 49 (22-57) | 0.137 | 
| ALT (U/L) | 14.95 (4.4-564) | 122.9 (7-1906) | 64 (8-855) | 41 (15-450.2) | < 0.01 | 
| AST (U/L) | 21.55 (11.0-38.5) | 75.5 (14-1499) | 56 (16-845) | 56 (19-634) | < 0.01 | 
| ALB (g/L) | 48.22 ± 2.51 | 38.01 ± 5.82 | 32.10 ± 6.87 | 34.56 ± 6.56 | < 0.01 | 
| HGB (g/L) | 147.79 ± 13.80 | 145.41 ± 17.74 | 126.33 ± 22.70 | 133.58 ± 22.5 | < 0.01 | 
| PLT (× 109/L) | 217 (117-328) | 152.5 (55-298) | 79 (28-303) | 124 (17-515) | < 0.01 | 
| APRI | 0.24 (0.1-0.5) | 1.25 (0.16-68.14) | 2.05 (0.24-42.25) | 1.49 (0.24-9.43) | < 0.01 | 
| HBV-DNA (Log10) | 0 (0-0) | 6.64 (1.3-8.91) | 4.96 (1.7-8.35) | 4.61 (1.7-7.88) | < 0.01 | 
            Table 2 Factors associated with serum hepcidin concentration in multiple linear regression models
        
    | Correlation analysis | Linear regression analysis | |||
| Characteristic | rho | P-value | Effect size | P -value | 
| Age (yr) | 0.3 | < 0.01 | 0.213 | 0.001 | 
| Gender | 0.01 | 0.986 | - | - | 
| ALT (U/L) | -0.095 | 0.141 | - | - | 
| AST (U/L) | -0.013 | 0.842 | - | - | 
| GGT (U/L) | 0.011 | 0.871 | - | - | 
| AKP (U/L) | 0.123 | 0.058 | - | - | 
| ALB (g/L) | -0.055 | 0.394 | - | - | 
| TBIL (μmol/L) | 0.108 | 0.096 | - | - | 
| TBA (μmol/L) | 0.196 | 0.002 | ||
| HBV-DNA (Log10) | -0.374 | < 0.01 | -0.282 | < 0.001 | 
| APRI | 0.114 | 0.077 | - | - | 
| RBC (× 1012/L) | -0.153 | 0.018 | ||
| WBC (× 109/L) | -0.119 | 0.065 | - | - | 
| PLT (× 109/L) | -0.195 | 0.002 | ||
| HGB (g/L) | -0.158 | 0.014 | ||
| MCV (fL) | 0.01 | 0.879 | - | - | 
| HCT (L/L) | -0.162 | 0.012 | ||
| INR | 0.188 | 0.003 | 0.198 | < 0.001 | 
| Serum iron (μmol/L) | 0.027 | 0.672 | - | - | 
| Total iron binding capacity (μmol/L) | -0.073 | 0.261 | - | - | 
| Serum ferritin (μg/L) | -0.13 | 0.836 | - | - | 
| Transferrin saturation (%) | 0.056 | 0.387 | - | - | 
| transferrin (g/L) | 0.002 | 0.98 | - | - | 
- Citation: Gao YH, Wang JY, Liu PY, Sun J, Wang XM, Wu RH, He XT, Tu ZK, Wang CG, Xu HQ, Niu JQ. Iron metabolism disorders in patients with hepatitis B-related liver diseases. World J Clin Cases 2018; 6(13): 600-610
 - URL: https://www.wjgnet.com/2307-8960/full/v6/i13/600.htm
 - DOI: https://dx.doi.org/10.12998/wjcc.v6.i13.600
 
